NM/CT 870 CZT

Bring theory to life with CZT

Improved lesion detectability¹

Assisting efforts to diagnose, stage disease earlier

Guide therapy planning decisions

With quantitative disease state and treatment response assessments

Theranostics capabilities

Use to enhance your full-service SPECT/CT practice

Productivity

Simple workflows for complex procedures

SPECT/CT as you have never seen it before

NM/CT 870 CZT is the third-generation of our general purpose digital SPECT/CT system powered by CZT technology. An important capability of NM/CT 870 CZT is the ability to image low energy and medium energy isotopes with energies up to 250 keV. Accessibility to the Medium Energy High Resolution & Sensitivity (MEHRS) collimator, via collimator exchange, will expand your SPECT/CT offering to include Theranostics applications.
FEATURES

A SPECT/CT system for true discovery

The latest generation offers the SmartConsole, CT features, and the capability of imaging the higher energy peaks of medium energy isotopes. Help bring your theories to life with a system designed to leverage all that CZT can do for a wide variety of procedures.
DESIGN

Designed for patient comfort and increased versatility

Using registered collimation, NM/CT 870 CZT contains detected events entirely within a single pixel aligned to one collimator hole, even at the outermost edges of the FOV. This reduction in dead space enables a system design can get closer to anatomies and increase patient comfort.

A patient-centric detector design with 67 percent reduction in brain reach makes certain exams more tolerable. Normally, cardiac SPECT scans require patients to extend and hold their arms above their head for a long duration. With NM/CT 870 CZT, scan time may be reduced by up to 75%² and the near frameless detector design can enable patients to hold their arms at a more comfortable angle.

PRODUCTIVITY

Switch to an all-digital workflow

SmartConsole is a productivity hub for hybrid imaging. Simplify the workflow for complex hybrid and quantitative protocols and allow technologists to review results directly at the scanner console. It allows physicians to review scans remotely from mobile devices. They can modify processing settings and initiate study processing anytime, anywhere across a LAN or a WAN.*
*Minimum hardware and software requirements apply.

SmartConsole enables a noticeable improvement in productivity. Now, a physician can provide their input remotely and digitally. For example, physicians can review a whole-body bone scan directly on their tablet or other mobile device and define the scan range limits they need from wherever they are. The time saved with this switch to a digital workflow helps make it possible to complete exams in predictable time slots.

BUILT FOR QUANTITATION

Quantitative SPECT/CT for every patient, every day

NM/CT 870 CZT is a SPECT/CT built for consistent, reproducible quantitation. Improvements to detector performance enable exceptional spatial and energy resolution. It also leverages CT-based attenuation and scatter correction along with Evolution3 image reconstruction. In addition, ever-increasing computational power enables precise camera calibration for less variation between exams.

Once your quantitative studies are acquired, SmartConsole - together with Xeleris - makes it easier to access them. Your quantitative SPECT/CT studies are automatically transferred directly to the PACS or other pre-defined DICOM destinations. An additional dataset in PET DICOM format allows you to review and evaluate images on the same devices you use to view your PET/CT studies, as adjacent information to the original SPECT/CT images.

PRODUCTIVITY

One home for all your molecular images

SmartConsole makes advanced procedures more accessible by transferring exams directly to the PACS or other pre-defined DICOM destinations with no operator intervention, even if SPECT/CT fusion is not supported, by exporting the studies in DICOM PET format. You can generate and send an additional dataset in PET DICOM format to enable quantitative SPECT results and SPECT SUV (Standard Uptake Value) on any PET DICOM compliant workstation or PACS. Referring physicians can review and evaluate your SPECT/CT exams with the same quality of information they have come to expect from your PET/CT, as adjunct information to the original SPECT/CT images.

See everything clearly now

As molecular imaging continues to move toward the development of disease-specific diagnoses and increasingly personalized care, resolution is important. Early disease detection is only possible with a high system resolution that enables visualization of finer anatomic detail.

The resolution to discover something new

With direct conversion detection, NM/CT 870 CZT has substantially improved system resolution⁴ by eliminating the signal loss and noise that comes with analog detection technology. It also uses a registered collimation design that aligns each collimator hole with a single detector pixel. This design eliminates the impact of collimator resolution that would normally affect the overall system resolution. The result is an improved contrast-to-noise ratio⁵ and spatial resolution down to 2.8 mm.⁶

CAPABILITIES

Key enhancements with NM/CT 870 CZT

Exceptional energy resolution

6.3% compared to 9.5%⁷

Improved SPECT contrast-to-noise ratio

Greater than 40%⁸

Greater optimal FOV

25% more than NaI detectors

Medium energy imaging

Enabled by Medium Energy High Resolution and Sensitivity (MEHRS) Collimator
DISCLAIMERS
1. In clinical practice, the use of NM/CT 870 CZT with WEHR collimator may improve lesion detectability depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose or scan time to obtain diagnostic image quality for the particular clinical task.
2. Together with WEHR collimator, Clarity 2D and Evolution3 and compared to Discovery NM/CT 670 Pro/ES/DR without Clarity 2D and Evolution3. As demonstrated in phantom testing using a bone scan protocol, and the NEMA IEC Body Phantom. The actual time/dose reduction depends on the clinical task, patient size, anatomical location and clinical practice.
3. In clinical practice, Evolution options3a (Evolution for Bone, Evolution for Cardiac, Evolution for Bone Planar) and Evolution Toolkit3b are recommended for use following consultation of a Nuclear Medicine physician, physicist and/or application specialist to determine the appropriate dose or scan time reduction to obtain diagnostic image quality for a particular clinical task, depending on the protocol adopted by the clinical site.
3a. Evolution Options - Evolution claims are supported by simulation of count statistics using default factory protocols and imaging of 99mTc based radiotracers with LEHR collimator on anthropomorphic phantom or realistic NCAT – SIMSET phantom followed by quantitative and qualitative images comparison.
3b. Evolution Toolkit - Evolution Toolkit claims are supported by simulation of full count statistics using lesion simulation phantom images based on various radiotracers and collimators and by showing that SPECT image quality reconstructed with Evolution Toolkit provide equivalent clinical information but have better signal-to-noise, contrast, and lesion resolution compared to the images reconstructed with FBP / OSEM.
4. NM/CT 870 CZT using WEHR and Clarity 2D. As compared to Discovery NM/CT 670 Pro / ES / DR.
5. NM/CT 870 CZT using WEHR. As demonstrated in NEMA IEC Body Phantom. As compared to Discovery NM/CT 670 Pro / ES / DR.
6. At detector surface.
7. As compared to Discovery NM/CT 670 Pro / ES / DR.
8. Demonstrated in phantom testing using NEMA IEC Body Phantom at 50% scan times with WEHR collimator and Evolution3. Compared to Discovery NM/CT 670 Pro/ES/DR.

JB01390XX

Have a question? We would love to hear from you.